EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE

EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE

Aim. To compare two initial doses (50 or 100mg/day) ofmetoprolol succinate in control released presentation (Betaloc ZOK, AstraZeneca) for achievement of target level of heart rate (HR) in patients with stable course of ischemic heart disease (IHD).Material and methods. 50 patients (34 men and 16 wo...

Full description

Bibliographic Details
Main Authors: S. N. Tolpygina, S. Y. Martsevich
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
: ischemic heart disease
heart rate
metoprolol succinate
Online Access:https://www.rpcardio.com/jour/article/view/1156

Internet

https://www.rpcardio.com/jour/article/view/1156

Similar Items